Global Finasteride Tablets market is expected to grow from US$ 130 million in 2025 to US$ 165 million in 2031; it is expected to grow at a CAGR of 4.1% from 2025 to 2031.

Global Finasteride Tablets Market Size and Outlook 2025-31

The global Finasteride Tablets market size is predicted to grow from US$ 130 million in 2025 to US$ 165 million in 2031; it is expected to grow at a CAGR of 4.1% from 2025 to 2031. The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report. Finasteride, sold under the brand names Proscar and Propecia among others, is a medication used for the treatment of benign prostatic hyperplasia (BPH) and male pattern baldness (MPB). United States market for Finasteride Tablets is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031. China market for Finasteride Tablets is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031. Europe market for Finasteride Tablets is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031. Global key Finasteride Tablets players cover Merck, Actavis, Sandoz, Teva Pharmaceuticals, Cipla, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024. Infinity Market Research newest research report, the Finasteride Tablets Industry Forecast looks at past sales and reviews total world Finasteride Tablets sales in 2024, providing a comprehensive analysis by region and market sector of projected Finasteride Tablets sales for 2025 through 2031. With Finasteride Tablets sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Finasteride Tablets industry. This Insight Report provides a comprehensive analysis of the global Finasteride Tablets landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Finasteride Tablets portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global Finasteride Tablets market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Finasteride Tablets and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Finasteride Tablets. This report presents a comprehensive overview, market shares, and growth opportunities of Finasteride Tablets market by product type, application, key manufacturers and key regions and countries. Segmentation by Type: &nbsp;&nbsp;&nbsp; 1mg Tablet &nbsp;&nbsp;&nbsp; 5mg Tablet Segmentation by Application: &nbsp;&nbsp;&nbsp; Benign Prostatic Hyperplasia &nbsp;&nbsp;&nbsp; Male Pattern Baldness &nbsp;&nbsp;&nbsp; Others This report also splits the market by region: &nbsp;&nbsp;&nbsp; Americas &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; United States &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Canada &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mexico &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Brazil &nbsp;&nbsp;&nbsp; APAC &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; China &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Japan &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Korea &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Southeast Asia &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; India &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Australia &nbsp;&nbsp;&nbsp; Europe &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Germany &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; France &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; UK &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Italy &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Russia &nbsp;&nbsp;&nbsp; Middle East & Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Egypt &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; South Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Israel &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Turkey &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the companys coverage, product portfolio, its market penetration. &nbsp;&nbsp;&nbsp; Merck &nbsp;&nbsp;&nbsp; Actavis &nbsp;&nbsp;&nbsp; Sandoz &nbsp;&nbsp;&nbsp; Teva Pharmaceuticals &nbsp;&nbsp;&nbsp; Cipla &nbsp;&nbsp;&nbsp; RelonChem &nbsp;&nbsp;&nbsp; Dr. Reddy &nbsp;&nbsp;&nbsp; Accord Pharmaceuticals &nbsp;&nbsp;&nbsp; Henan Topfond &nbsp;&nbsp;&nbsp; Zhejiang CONBA Pharmaceutical &nbsp;&nbsp;&nbsp; Shandong Renhetang Pharmaceutical &nbsp;&nbsp;&nbsp; Guangdong Eashu Pharmacetical Key Questions Addressed in this Report What is the 10-year outlook for the global Finasteride Tablets market? What factors are driving Finasteride Tablets market growth, globally and by region? Which technologies are poised for the fastest growth by market and region? How do Finasteride Tablets market opportunities vary by end market size? How does Finasteride Tablets break out by Type, by Application?

1 Scope of the Report &nbsp;1.1 Market Introduction &nbsp;1.2 Years Considered &nbsp;1.3 Research Objectives &nbsp;1.4 Market Research Methodology &nbsp;1.5 Research Process and Data Source &nbsp;1.6 Economic Indicators &nbsp;1.7 Currency Considered &nbsp;1.8 Market Estimation Caveats 2 Executive Summary &nbsp;2.1 World Market Overview &nbsp;2.1.1 Global Finasteride Tablets Annual Sales 2020-2031 &nbsp;2.1.2 World Current & Future Analysis for Finasteride Tablets by Geographic Region, 2020, 2024 & 2031 &nbsp;2.1.3 World Current & Future Analysis for Finasteride Tablets by Country/Region, 2020, 2024 & 2031 &nbsp;2.2 Finasteride Tablets Segment by Type &nbsp;2.2.1 1mg Tablet &nbsp;2.2.2 5mg Tablet &nbsp;2.3 Finasteride Tablets Sales by Type &nbsp;2.3.1 Global Finasteride Tablets Sales Market Share by Type (2020-2025) &nbsp;2.3.2 Global Finasteride Tablets Revenue and Market Share by Type (2020-2025) &nbsp;2.3.3 Global Finasteride Tablets Sale Price by Type (2020-2025) &nbsp;2.4 Finasteride Tablets Segment by Application &nbsp;2.4.1 Benign Prostatic Hyperplasia &nbsp;2.4.2 Male Pattern Baldness &nbsp;2.4.3 Others &nbsp;2.5 Finasteride Tablets Sales by Application &nbsp;2.5.1 Global Finasteride Tablets Sale Market Share by Application (2020-2025) &nbsp;2.5.2 Global Finasteride Tablets Revenue and Market Share by Application (2020-2025) &nbsp;2.5.3 Global Finasteride Tablets Sale Price by Application (2020-2025) 3 Global by Company &nbsp;3.1 Global Finasteride Tablets Breakdown Data by Company &nbsp;3.1.1 Global Finasteride Tablets Annual Sales by Company (2020-2025) &nbsp;3.1.2 Global Finasteride Tablets Sales Market Share by Company (2020-2025) &nbsp;3.2 Global Finasteride Tablets Annual Revenue by Company (2020-2025) &nbsp;3.2.1 Global Finasteride Tablets Revenue by Company (2020-2025) &nbsp;3.2.2 Global Finasteride Tablets Revenue Market Share by Company (2020-2025) &nbsp;3.3 Global Finasteride Tablets Sale Price by Company &nbsp;3.4 Key Manufacturers Finasteride Tablets Producing Area Distribution, Sales Area, Product Type &nbsp;3.4.1 Key Manufacturers Finasteride Tablets Product Location Distribution &nbsp;3.4.2 Players Finasteride Tablets Products Offered &nbsp;3.5 Market Concentration Rate Analysis &nbsp;3.5.1 Competition Landscape Analysis &nbsp;3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025) &nbsp;3.6 New Products and Potential Entrants &nbsp;3.7 Market M&A Activity & Strategy 4 World Historic Review for Finasteride Tablets by Geographic Region &nbsp;4.1 World Historic Finasteride Tablets Market Size by Geographic Region (2020-2025) &nbsp;4.1.1 Global Finasteride Tablets Annual Sales by Geographic Region (2020-2025) &nbsp;4.1.2 Global Finasteride Tablets Annual Revenue by Geographic Region (2020-2025) &nbsp;4.2 World Historic Finasteride Tablets Market Size by Country/Region (2020-2025) &nbsp;4.2.1 Global Finasteride Tablets Annual Sales by Country/Region (2020-2025) &nbsp;4.2.2 Global Finasteride Tablets Annual Revenue by Country/Region (2020-2025) &nbsp;4.3 Americas Finasteride Tablets Sales Growth &nbsp;4.4 APAC Finasteride Tablets Sales Growth &nbsp;4.5 Europe Finasteride Tablets Sales Growth &nbsp;4.6 Middle East & Africa Finasteride Tablets Sales Growth 5 Americas &nbsp;5.1 Americas Finasteride Tablets Sales by Country &nbsp;5.1.1 Americas Finasteride Tablets Sales by Country (2020-2025) &nbsp;5.1.2 Americas Finasteride Tablets Revenue by Country (2020-2025) &nbsp;5.2 Americas Finasteride Tablets Sales by Type (2020-2025) &nbsp;5.3 Americas Finasteride Tablets Sales by Application (2020-2025) &nbsp;5.4 United States &nbsp;5.5 Canada &nbsp;5.6 Mexico &nbsp;5.7 Brazil 6 APAC &nbsp;6.1 APAC Finasteride Tablets Sales by Region &nbsp;6.1.1 APAC Finasteride Tablets Sales by Region (2020-2025) &nbsp;6.1.2 APAC Finasteride Tablets Revenue by Region (2020-2025) &nbsp;6.2 APAC Finasteride Tablets Sales by Type (2020-2025) &nbsp;6.3 APAC Finasteride Tablets Sales by Application (2020-2025) &nbsp;6.4 China &nbsp;6.5 Japan &nbsp;6.6 South Korea &nbsp;6.7 Southeast Asia &nbsp;6.8 India &nbsp;6.9 Australia &nbsp;6.10 China Taiwan 7 Europe &nbsp;7.1 Europe Finasteride Tablets by Country &nbsp;7.1.1 Europe Finasteride Tablets Sales by Country (2020-2025) &nbsp;7.1.2 Europe Finasteride Tablets Revenue by Country (2020-2025) &nbsp;7.2 Europe Finasteride Tablets Sales by Type (2020-2025) &nbsp;7.3 Europe Finasteride Tablets Sales by Application (2020-2025) &nbsp;7.4 Germany &nbsp;7.5 France &nbsp;7.6 UK &nbsp;7.7 Italy &nbsp;7.8 Russia 8 Middle East & Africa &nbsp;8.1 Middle East & Africa Finasteride Tablets by Country &nbsp;8.1.1 Middle East & Africa Finasteride Tablets Sales by Country (2020-2025) &nbsp;8.1.2 Middle East & Africa Finasteride Tablets Revenue by Country (2020-2025) &nbsp;8.2 Middle East & Africa Finasteride Tablets Sales by Type (2020-2025) &nbsp;8.3 Middle East & Africa Finasteride Tablets Sales by Application (2020-2025) &nbsp;8.4 Egypt &nbsp;8.5 South Africa &nbsp;8.6 Israel &nbsp;8.7 Turkey &nbsp;8.8 GCC Countries 9 Market Drivers, Challenges and Trends &nbsp;9.1 Market Drivers & Growth Opportunities &nbsp;9.2 Market Challenges & Risks &nbsp;9.3 Industry Trends 10 Manufacturing Cost Structure Analysis &nbsp;10.1 Raw Material and Suppliers &nbsp;10.2 Manufacturing Cost Structure Analysis of Finasteride Tablets &nbsp;10.3 Manufacturing Process Analysis of Finasteride Tablets &nbsp;10.4 Industry Chain Structure of Finasteride Tablets 11 Marketing, Distributors and Customer &nbsp;11.1 Sales Channel &nbsp;11.1.1 Direct Channels &nbsp;11.1.2 Indirect Channels &nbsp;11.2 Finasteride Tablets Distributors &nbsp;11.3 Finasteride Tablets Customer 12 World Forecast Review for Finasteride Tablets by Geographic Region &nbsp;12.1 Global Finasteride Tablets Market Size Forecast by Region &nbsp;12.1.1 Global Finasteride Tablets Forecast by Region (2026-2031) &nbsp;12.1.2 Global Finasteride Tablets Annual Revenue Forecast by Region (2026-2031) &nbsp;12.2 Americas Forecast by Country (2026-2031) &nbsp;12.3 APAC Forecast by Region (2026-2031) &nbsp;12.4 Europe Forecast by Country (2026-2031) &nbsp;12.5 Middle East & Africa Forecast by Country (2026-2031) &nbsp;12.6 Global Finasteride Tablets Forecast by Type (2026-2031) &nbsp;12.7 Global Finasteride Tablets Forecast by Application (2026-2031) 13 Key Players Analysis &nbsp;13.1 Merck &nbsp;13.1.1 Merck Company Information &nbsp;13.1.2 Merck Finasteride Tablets Product Portfolios and Specifications &nbsp;13.1.3 Merck Finasteride Tablets Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.1.4 Merck Main Business Overview &nbsp;13.1.5 Merck Latest Developments &nbsp;13.2 Actavis &nbsp;13.2.1 Actavis Company Information &nbsp;13.2.2 Actavis Finasteride Tablets Product Portfolios and Specifications &nbsp;13.2.3 Actavis Finasteride Tablets Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.2.4 Actavis Main Business Overview &nbsp;13.2.5 Actavis Latest Developments &nbsp;13.3 Sandoz &nbsp;13.3.1 Sandoz Company Information &nbsp;13.3.2 Sandoz Finasteride Tablets Product Portfolios and Specifications &nbsp;13.3.3 Sandoz Finasteride Tablets Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.3.4 Sandoz Main Business Overview &nbsp;13.3.5 Sandoz Latest Developments &nbsp;13.4 Teva Pharmaceuticals &nbsp;13.4.1 Teva Pharmaceuticals Company Information &nbsp;13.4.2 Teva Pharmaceuticals Finasteride Tablets Product Portfolios and Specifications &nbsp;13.4.3 Teva Pharmaceuticals Finasteride Tablets Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.4.4 Teva Pharmaceuticals Main Business Overview &nbsp;13.4.5 Teva Pharmaceuticals Latest Developments &nbsp;13.5 Cipla &nbsp;13.5.1 Cipla Company Information &nbsp;13.5.2 Cipla Finasteride Tablets Product Portfolios and Specifications &nbsp;13.5.3 Cipla Finasteride Tablets Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.5.4 Cipla Main Business Overview &nbsp;13.5.5 Cipla Latest Developments &nbsp;13.6 RelonChem &nbsp;13.6.1 RelonChem Company Information &nbsp;13.6.2 RelonChem Finasteride Tablets Product Portfolios and Specifications &nbsp;13.6.3 RelonChem Finasteride Tablets Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.6.4 RelonChem Main Business Overview &nbsp;13.6.5 RelonChem Latest Developments &nbsp;13.7 Dr. Reddy &nbsp;13.7.1 Dr. Reddy Company Information &nbsp;13.7.2 Dr. Reddy Finasteride Tablets Product Portfolios and Specifications &nbsp;13.7.3 Dr. Reddy Finasteride Tablets Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.7.4 Dr. Reddy Main Business Overview &nbsp;13.7.5 Dr. Reddy Latest Developments &nbsp;13.8 Accord Pharmaceuticals &nbsp;13.8.1 Accord Pharmaceuticals Company Information &nbsp;13.8.2 Accord Pharmaceuticals Finasteride Tablets Product Portfolios and Specifications &nbsp;13.8.3 Accord Pharmaceuticals Finasteride Tablets Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.8.4 Accord Pharmaceuticals Main Business Overview &nbsp;13.8.5 Accord Pharmaceuticals Latest Developments &nbsp;13.9 Henan Topfond &nbsp;13.9.1 Henan Topfond Company Information &nbsp;13.9.2 Henan Topfond Finasteride Tablets Product Portfolios and Specifications &nbsp;13.9.3 Henan Topfond Finasteride Tablets Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.9.4 Henan Topfond Main Business Overview &nbsp;13.9.5 Henan Topfond Latest Developments &nbsp;13.10 Zhejiang CONBA Pharmaceutical &nbsp;13.10.1 Zhejiang CONBA Pharmaceutical Company Information &nbsp;13.10.2 Zhejiang CONBA Pharmaceutical Finasteride Tablets Product Portfolios and Specifications &nbsp;13.10.3 Zhejiang CONBA Pharmaceutical Finasteride Tablets Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.10.4 Zhejiang CONBA Pharmaceutical Main Business Overview &nbsp;13.10.5 Zhejiang CONBA Pharmaceutical Latest Developments &nbsp;13.11 Shandong Renhetang Pharmaceutical &nbsp;13.11.1 Shandong Renhetang Pharmaceutical Company Information &nbsp;13.11.2 Shandong Renhetang Pharmaceutical Finasteride Tablets Product Portfolios and Specifications &nbsp;13.11.3 Shandong Renhetang Pharmaceutical Finasteride Tablets Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.11.4 Shandong Renhetang Pharmaceutical Main Business Overview &nbsp;13.11.5 Shandong Renhetang Pharmaceutical Latest Developments &nbsp;13.12 Guangdong Eashu Pharmacetical &nbsp;13.12.1 Guangdong Eashu Pharmacetical Company Information &nbsp;13.12.2 Guangdong Eashu Pharmacetical Finasteride Tablets Product Portfolios and Specifications &nbsp;13.12.3 Guangdong Eashu Pharmacetical Finasteride Tablets Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.12.4 Guangdong Eashu Pharmacetical Main Business Overview &nbsp;13.12.5 Guangdong Eashu Pharmacetical Latest Developments 14 Research Findings and Conclusion

Report	Global Finasteride Tablets Market Growth 2025-2031
Selected License	Multi ID: LPI24993

Buyer Information

Order Summary